Phase II trial of the effects of Pill-Plus triple-hormone oral contraceptive vs oral contraceptives alone on the sexual arousability and vascular component of sexual arousal response in women
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2010
At a glance
- Drugs Drospirenone/estradiol/prasterone (Primary) ; Estradiol/drospirenone
- Indications Female sexual dysfunction
- Focus Pharmacodynamics
- 01 Jul 2010 Positive clinical results announced in a BioSante Pharmaceuticals media release. Additional data will be reported upon full publication of the study results.
- 30 Jun 2007 New trial record.